TY - JOUR
KW - HCV
KW - Hepatitis C
KW - models of care
KW - OUD
KW - Opioid Treatment Program
KW - opioid use disorder
KW - Retention
KW - treatment
AU - B. Severe
AU - J. M. Tetrault
AU - L. Madden
AU - R. Heimer
A1 - 
AD - Yale University School of Public Health, 60 College Street, New Haven, Connecticut, 06510, USA. Electronic address: Severe.brooke@gmail.com.; Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA; APT Foundation, 1 Long Wharf Drive, New Haven, Connecticut 06511, USA.; Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA; APT Foundation, 1 Long Wharf Drive, New Haven, Connecticut 06511, USA.; Yale University School of Public Health, 60 College Street, New Haven, Connecticut, 06510, USA.
BT - Drug and alcohol dependence
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - Ireland
DO - 10.1016/j.drugalcdep.2020.108116
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PP - Ireland
PY - 2020
SN - 1879-0046; 0376-8716
SP - 108116
T1 - Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention
T2 - Drug and alcohol dependence
TI - Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 32599493
U3 - 10.1016/j.drugalcdep.2020.108116
VL - 213
VO - 1879-0046; 0376-8716
Y1 - 2020
Y2 - Jun 12
ER -